• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[乳腺癌治疗的成本效益评估。癌症预防中心1975 - 1985年的比较分析]

[Cost effectiveness evaluation of breast cancer therapy. Comparative analysis 1975-1985 in a cancer prevention center].

作者信息

Lapeyre-Mestre M, Daly-Schveitzer N, Boussin G, Delande G

机构信息

Département d'Information Médicale, Centre Claudius Regaud, Toulouse.

出版信息

Rev Epidemiol Sante Publique. 1993;41(5):397-406.

PMID:8284480
Abstract

We describe a retrospective and comparative assessment of the medical care of breast cancer among women in a French comprehensive cancer center, the Centre Claudius Regaud. There was no significant difference for the clinical results between two cohorts of women, treated in 1975 and 1985 respectively, for equivalent stages of disease. The overall increase in survival resulted mainly from early diagnosis. Locoregional treatment cost and conservative treatment cost, from official Social Security costs, did not increase between the two periods. However, a high risk of metastasis risk during the first treatment, or recurrence during the follow-up, resulted in differences in cost-effectiveness between 1975 and 1985. Although these results must be interpreted with caution, this analysis raises strategic questions about the suitability of some medical practices, particularly in the care of evolutive neoplasm.

摘要

我们描述了在法国综合癌症中心克劳迪乌斯·雷加德中心对乳腺癌女性患者医疗护理进行的一项回顾性比较评估。在疾病分期相同的情况下,分别于1975年和1985年接受治疗的两组女性患者的临床结果没有显著差异。生存率的总体提高主要源于早期诊断。两个时期之间,来自官方社会保障费用的局部区域治疗成本和保守治疗成本并未增加。然而,首次治疗期间转移风险高或随访期间复发导致了1975年和1985年之间成本效益的差异。尽管这些结果必须谨慎解读,但该分析提出了关于某些医疗实践适用性的战略问题,尤其是在进展性肿瘤的护理方面。

相似文献

1
[Cost effectiveness evaluation of breast cancer therapy. Comparative analysis 1975-1985 in a cancer prevention center].[乳腺癌治疗的成本效益评估。癌症预防中心1975 - 1985年的比较分析]
Rev Epidemiol Sante Publique. 1993;41(5):397-406.
2
[Advanced breast cancer: an evaluation of the cost of recurrence].[晚期乳腺癌:复发成本评估]
Bull Cancer. 1999 Jun;86(6):585-90.
3
[Cost of treatment and follow up of breast cancer: a retrospective assessment in a comprehensive cancer centre].[乳腺癌的治疗及随访费用:在一家综合癌症中心的回顾性评估]
Bull Cancer. 2002 Jun;89(6):635-42.
4
Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study.工作年龄女性乳腺癌后淋巴水肿的发病率、治疗费用及并发症:一项为期2年的随访研究。
J Clin Oncol. 2009 Apr 20;27(12):2007-14. doi: 10.1200/JCO.2008.18.3517. Epub 2009 Mar 16.
5
Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancer.他莫昔芬辅助治疗5年后,来曲唑延长辅助治疗对绝经后早期乳腺癌女性的成本效益分析。
Am J Manag Care. 2006 Jul;12(7):374-86.
6
The cost effectiveness of tamoxifen in the prevention of breast cancer.他莫昔芬在预防乳腺癌方面的成本效益。
Am J Manag Care. 1999 Jun;5(6 Suppl):S389-406.
7
Locoregional recurrence of breast cancer: a retrospective comparison of treatment methods.乳腺癌的局部区域复发:治疗方法的回顾性比较
Neoplasma. 2002;49(6):426-31.
8
259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.应用USC/范纽斯预后指数的259例乳腺导管原位癌患者:长期随访的回顾性研究
Breast Cancer Res Treat. 2008 Jun;109(3):405-16. doi: 10.1007/s10549-007-9668-7. Epub 2007 Aug 9.
9
[Macro-economic calculation of spending versus micro-economic follow-up of costs of breast cancer].[乳腺癌支出的宏观经济计算与成本的微观经济跟踪]
Rev Epidemiol Sante Publique. 2002 Dec;50(6):581-92.
10
[Evidence-based radiotherapy in the treatment of operable breast cancer: results in the 1990-ies].[基于证据的放射治疗在可手术乳腺癌治疗中的应用:20世纪90年代的结果]
Orv Hetil. 2000 Jul 9;141(28):1551-5.